Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse-Reference-Cited by-同舟云学术

Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse

Published:2010-03-24 Issue:4 Volume:12 Page:319-322
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Abbate Antonio¹²,Van Tassell Benjamin W.¹²³,Seropian Ignacio M.¹²³,Toldo Stefano¹²,Robati Roshanak¹,Varma Amit¹,Salloum Fadi N.¹,Smithson Lisa²,Dinarello Charles A.⁴

Affiliation:

1. Division of Cardiology/VCU Pauley Heart Center; Virginia Commonwealth University; 1200 East Broad Street - West Hospital, 10th Floor, East Wing, Room 1041, PO Box 980281 Richmond VA 23298-0281 USA

2. Victoria Johnson Center; Virginia Commonwealth University; Richmond VA USA

3. School of Pharmacy; Virginia Commonwealth University; Richmond VA USA

4. School of Medicine; University of Colorado; Aurora CO USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. The immune system and cardiac repair;Frangogiannis;Pharm Res,2008

2. Immunological and inflammatory functions of the interleukin-1 family;Dinarello;Annu Rev Immunol,2009

3. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling;Bujak;Am J Pathol,2008

4. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction;Abbate;Circulation,2008

5. Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study);Crossman;Trials,2008

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Roles of IL-1, IL-6, IL-10, IL-17, IL-18, 1L-22, IL-33, and IL-37 in Various Cardiovascular Diseases With Potential Insights for Targeted Immunotherapy;Cureus;2023-07-26

2. Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects;Antioxidants;2023-07-07

3. Inflammasomes as mediators of inflammation in HIV-1 infection;Translational Research;2023-02

4. Inflammation macrophages contribute to cardiac homeostasis;Cardiology Plus;2023-01

5. Role of IL-1 in bacterial infections;Multifaceted Role of IL-1 in Cancer and Inflammation;2023